Original Research
Published on 29 Feb 2024
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells
in Alloimmunity and Transplantation
- 6,511 views
- 5 citations
Original Research
Published on 29 Feb 2024
in Alloimmunity and Transplantation
Mini Review
Published on 27 Feb 2024
in Alloimmunity and Transplantation
Review
Published on 23 Feb 2024
in Alloimmunity and Transplantation
Original Research
Published on 22 Feb 2024
in Alloimmunity and Transplantation
Editorial
Published on 20 Feb 2024
in Alloimmunity and Transplantation
Review
Published on 16 Feb 2024
in Alloimmunity and Transplantation
Original Research
Published on 13 Feb 2024
in Alloimmunity and Transplantation
Review
Published on 08 Feb 2024
in Alloimmunity and Transplantation
Opinion
Published on 07 Feb 2024
in Alloimmunity and Transplantation
Review
Published on 07 Feb 2024
in Alloimmunity and Transplantation
Original Research
Published on 07 Feb 2024
in Alloimmunity and Transplantation
Original Research
Published on 07 Feb 2024
in Alloimmunity and Transplantation
Review
Published on 06 Feb 2024
in Alloimmunity and Transplantation
Review
Published on 06 Feb 2024
in Alloimmunity and Transplantation
Original Research
Published on 01 Feb 2024
in Alloimmunity and Transplantation
Original Research
Published on 01 Feb 2024
in Alloimmunity and Transplantation